$257MSeries D, 28 January 2026
Series D to build automated smart factories in the US, the Netherlands and Japan ahead of commercial production in 2027.
- Amount
- $257M
- Stage
- Series D
- Announced
- 28 January 2026
- Lead
- BlackRock
- Other investors
- Eclipse, T. Rowe Price, Baillie Gifford, Gates Frontier, Duquesne Family Office, Intuitive Ventures, EDBI
- Use of funds
- Series D to build automated smart factories in the US, the Netherlands and Japan ahead of commercial production in 2027.
- Checked
- Announced by the company
- Sources
- Cellares: $257 Million Series D Closed To Scale Automated Cell Therapy Manufacturing businesswire.com
Cellares: $257 Million Series D Closed To Scale Automated Cell Therapy Manufacturing pulse2.com